Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OsteoAMP Select
- Development stage
- Unknown
- Lead developer
- Bioventus
- Administration
- Topical
01
Overview
OsteoAMP Select is an allograft bone graft substitute developed by Bioventus. It is a biologic tissue product regulated as a 361 HCT/P (Human Cells, Tissues, and Cellular and Tissue-Based Products), consisting of 100% donor-derived bone tissue without synthetic carriers. The product is processed using a proprietary method designed to retain a wide array of endogenous growth factors, providing both osteoconductive (scaffold for bone growth) and osteoinductive (stimulation of new bone formation) properties. It is available in multiple formats, including flowable, fibers, and sponges, and is primarily used in orthopedic procedures such as lumbar, cervical, and foot and ankle fusions.
- Brand names
- OsteoAMP Select
Beyond the preview
Go deeper on OsteoAMP Select.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OsteoAMP Select.